| 1 |
tumor necrosis factor
(33504 times)
|
Allergy and Immunology
(5388 times)
|
IL (10161 times)
LPS (3362 times)
IFN (2853 times)
|
1978 Tumour-necrosis factor from the rabbit. II. Production by monocytes.
|
| 2 |
TNF-alpha
(69 times)
|
Allergy and Immunology
(20 times)
|
LPS (5 times)
IL1B (4 times)
TNF-alpha (4 times)
|
1989 Tumor necrosis factor-mediated cytotoxicity by tumor-associated macrophages.
|
| 3 |
tumor necrosis factor/cachectin
(29 times)
|
Allergy and Immunology
(9 times)
|
LPS (6 times)
IL-1 (5 times)
IL-6 (3 times)
|
1986 Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.
|
| 4 |
2,4,7-trinitro-9-fluorenone
(22 times)
|
Chemistry
(12 times)
|
CT (5 times)
CTC (4 times)
DLC (2 times)
|
1983 Genotoxic properties of 2,4,7-trinitro-9-fluorenone.
|
| 5 |
tenofovir
(16 times)
|
Pharmacology
(5 times)
|
ICH (2 times)
NRTIs (2 times)
RSD (2 times)
|
2003 Thymidine analogue-sparing highly active antiretroviral therapy (HAART).
|
| 6 |
treated with antitumor necrosis factor
(9 times)
|
Dermatology
(3 times)
|
IBD (2 times)
IL (2 times)
RA (2 times)
|
2009 [Sequential histological and immunohistochemical assessment of proliferation and apoptotic markers during treatment of psoriasis with antitumor necrosis factor alpha (infliximab)].
|
| 7 |
trinitrofluorenone
(6 times)
|
Chemistry
(3 times)
|
CT (2 times)
2AA (1 time)
AP (1 time)
|
1989 Genotoxicity and genotoxic enhancing effect of tetrandrine in Salmonella typhimurium.
|
| 8 |
TNF-alpha and TNF-beta
(3 times)
|
Allergy and Immunology
(1 time)
|
TNF-alpha (2 times)
ACD (1 time)
CD (1 time)
|
1990 Expression of two distinct cytolytic mechanisms among murine CD4 subsets.
|
| 9 |
transferrin
(3 times)
|
Health Services for the Aged
(1 time)
|
ALB (3 times)
PA (3 times)
TP (2 times)
|
1992 [The importance of a diet survey in the early detection of malnutrition in the elderly].
|
| 10 |
anti-tumor necrosis factor inhibitor
(2 times)
|
Rheumatic Diseases
(2 times)
|
BS (1 time)
csDMARDs (1 time)
NSAIDs (1 time)
|
2014 A long-term follow-up of Japanese mother and her daughter with Blau syndrome: Effective treatment of anti-TNF inhibitors and useful diagnostic tool of joint ultrasound examination.
|
| 11 |
Tahoe National Forest
(2 times)
|
Environmental Health
(2 times)
|
GIS (1 time)
|
2007 Nitrous oxide nitrification and denitrification 15N enrichment factors from Amazon forest soils.
|
| 12 |
thickened nuchal fold
(2 times)
|
Obstetrics
(1 time)
|
CMA (1 time)
CNVs (1 time)
EIF (1 time)
|
2017 The recurrence of sonographic 'soft markers': ominous sign or 'just' genetics?
|
| 13 |
tiger nut fibre
(2 times)
|
Nutritional Sciences
(2 times)
|
---
|
2010 Effect of tiger nut fibre on quality characteristics of pork burger.
|
| 14 |
transforming growth factor
(2 times)
|
Nephrology
(1 time)
|
ACE (1 time)
IFN (1 time)
Ig (1 time)
|
2001 Role of angiotensin II in tubulointerstitial injury.
|
| 15 |
tumor necrosis-inducing factor
(2 times)
|
Cell Biology
(1 time)
|
DMSO (1 time)
FELC (1 time)
|
1982 Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells.
|
| 16 |
tumor nuclear factor
(2 times)
|
Endocrine System Diseases
(1 time)
|
IL (2 times)
CAD (1 time)
CVDs (1 time)
|
2014 Association of metabolic syndrome with severity of coronary artery disease.
|
| 17 |
Turmeric nanofibers
(2 times)
|
Biomimetics
(2 times)
|
ASF (1 time)
CUR (1 time)
DSC (1 time)
|
2017 Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber.
|
| 18 |
2,4,5,7-tetranitrofluorescein
(1 time)
|
Molecular Biology
(1 time)
|
CTAC (1 time)
DMSO (1 time)
|
2005 2,4,5,7-Tetranitrofluorescein in solutions: novel type of tautomerism in hydroxyxanthene series as detected by various spectral methods.
|
| 19 |
9-dicyanomethylene-2,4,7-trinitrofluorene
(1 time)
|
Chemistry
(1 time)
|
---
|
2008 Molecular clips with extended aromatic sidewalls as receptors for electron-acceptor molecules. Synthesis and NMR, photophysical, and electrochemical properties.
|
| 20 |
anti-(alpha)-tumor necrosis factor
(1 time)
|
Ophthalmology
(1 time)
|
CM (1 time)
ELISA (1 time)
hRPE (1 time)
|
1997 Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
|
| 21 |
anti-TNF-alpha
(1 time)
|
Dermatology
(1 time)
|
---
|
2019 Psoriasis and the TNF/IL23/IL17 axis.
|
| 22 |
bisporphyrin-trinitrofluorenone
(1 time)
|
Biology
(1 time)
|
---
|
2017 Sequence-controlled supramolecular terpolymerization directed by specific molecular recognitions.
|
| 23 |
compounds--tumor necrosis factor
(1 time)
|
Pulmonary Medicine
(1 time)
|
---
|
2011 Pulmonary infectious diseases in patients with primary immunodeficiency and those treated with biologic immunomodulating agents.
|
| 24 |
HAT6-trinitrofluorenone
(1 time)
|
Nanotechnology
(1 time)
|
---
|
2015 Columnar liquid crystals in cylindrical nanoconfinement.
|
| 25 |
IFN-beta+IL-1beta+tumor necrosis factor
(1 time)
|
Complementary Therapies
(1 time)
|
IFN (1 time)
IL (1 time)
iNOS (1 time)
|
2013 Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
|
| 26 |
interleukin-10:Tumor necrosis factor
(1 time)
|
Communicable Diseases
(1 time)
|
IL (1 time)
IL-10 (1 time)
|
2000 Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications.
|
| 27 |
intra-tracheal instillation in each mouse of treated
(1 time)
|
Physiological Phenomena
(1 time)
|
PBS (1 time)
RARs (1 time)
TNF-alpha (1 time)
|
2017 Hypersensitivity of Vagal Pulmonary Afferents Induced by Tumor Necrosis Factor Alpha in Mice.
|
| 28 |
lentivirustumor necrosis factor
(1 time)
|
Molecular Biology
(1 time)
|
COX (1 time)
MMP (1 time)
PBS (1 time)
|
2015 Targeted knockout of TNF-alpha by injection of lentivirus-mediated siRNA into the subacromial bursa for the treatment of subacromial bursitis in rats.
|
| 29 |
pre-treatment with BAY11-7082 significantly
(1 time)
|
Chemistry
(1 time)
|
cGMP (1 time)
HCtAEC (1 time)
IL-6 (1 time)
|
2019 NFkappaB Inhibition Mitigates Serum Amyloid A-Induced Pro-Atherogenic Responses in Endothelial Cells and Leukocyte Adhesion and Adverse Changes to Endothelium Function in Isolated Aorta.
|
| 30 |
serum-tuberculostasis neutralizing factor
(1 time)
|
Allergy and Immunology
(1 time)
|
Tr (1 time)
|
1971 Mechanism of Tuberculostasis in Mammalian Serum III. Neutralization of Serum Tuberculostasis by Mycobactin.
|
| 31 |
T-cell depletion and antitumour necrosis factor
(1 time)
|
Dermatology
(1 time)
|
OS (1 time)
|
2009 A comprehensive review of biomarkers in psoriasis.
|
| 32 |
tacrolimus, and antitumor necrosis factor
(1 time)
|
Drug Therapy
(1 time)
|
JCA (1 time)
MMF (1 time)
VKH (1 time)
|
2006 Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.
|
| 33 |
tactile nerve fiber
(1 time)
|
Neurosciences
(1 time)
|
TENS (1 time)
|
2017 A 3D Computational Model of Transcutaneous Electrical Nerve Stimulation for Estimating Abeta Tactile Nerve Fiber Excitability.
|
| 34 |
tapered nanofiber
(1 time)
|
Nanotechnology
(1 time)
|
MWB (1 time)
|
2020 A broadband and low-power light-control-light effect in a fiber-optic nano-optomechanical system.
|
| 35 |
tapered optical nanofiber
(1 time)
|
Medicine
(1 time)
|
---
|
2008 Observation of nonlinear optical interactions of ultralow levels of light in a tapered optical nanofiber embedded in a hot rubidium vapor.
|
| 36 |
target for antitumor necrosis factor
(1 time)
|
Chemistry
(1 time)
|
NF-kappaB (1 time)
|
2017 Discovery of Potent Small-Molecule Inhibitors of Ubiquitin-Conjugating Enzyme UbcH5c from alpha-Santonin Derivatives.
|
| 37 |
Tears Naturale Free
(1 time)
|
Eye Diseases
(1 time)
|
CMC (1 time)
HA (1 time)
NS (1 time)
|
2018 Evaluation of artificial tears on cornea epithelium healing.
|
| 38 |
tenofovir disoproxil fumarate
(1 time)
|
Drug Therapy
(1 time)
|
CI range (1 time)
EMT (1 time)
|
2016 Comparative bioavailability of two tablet formulations of emtricitabine/tenofovir in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
|
| 39 |
Tensor Network Features
(1 time)
|
Biomedical Engineering
(1 time)
|
EEG (1 time)
|
2020 Tensor-Based EEG Network Formation and Feature Extraction for Cross-Session Driving Drowsiness Detection.
|
| 40 |
test, rats received oxygen alone or antitumor necrosis factor
(1 time)
|
Cardiology
(1 time)
|
EG (1 time)
HS/R (1 time)
MAP (1 time)
|
2020 Hydrogen Gas Inhalation Attenuates Endothelial Glycocalyx Damage and Stabilizes Hemodynamics in a Rat Hemorrhagic Shock Model.
|
| 41 |
tetranucleotide frequency
(1 time)
|
Microbiological Phenomena
(1 time)
|
GH (1 time)
|
2013 Coupled high-throughput functional screening and next generation sequencing for identification of plant polymer decomposing enzymes in metagenomic libraries.
|
| 42 |
Tetric N-Flow Bulk Fill
(1 time)
|
Tooth Diseases
(1 time)
|
DOC (1 time)
FBF (1 time)
TNC (1 time)
|
2020 The Effect of Shade and Thickness on the Depth of Cure of Bulk-Fill Composites with Different Viscosities.
|
| 43 |
TF and cytokines
(1 time)
|
Vascular Diseases
(1 time)
|
PMN (1 time)
TF (1 time)
|
1998 [Modulators of leukocytic functions].
|
| 44 |
than a decade ago, antitumor necrosis factor
(1 time)
|
Biochemistry
(1 time)
|
ADAbs (1 time)
IBD (1 time)
|
2014 TNF blocking therapies and immunomonitoring in patients with inflammatory bowel disease.
|
| 45 |
therapeutic medications such as antitumor necrosis factor
(1 time)
|
Pharmacology
(1 time)
|
CD (1 time)
IBD (1 time)
IL (1 time)
|
2020 Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
|
| 46 |
Therapeutic Nursing Function
(1 time)
|
Nursing
(1 time)
|
---
|
1986 Indicators of quality in nursing care--an alternative approach.
|
| 47 |
therapy with adalimumab, an antitumor necrosis factor
(1 time)
|
Medicine
(1 time)
|
DADS (1 time)
|
2015 DADS neuropathy associated with anti-TNF-alpha therapy.
|
| 48 |
Thermal Neutron Facility
(1 time)
|
Nuclear Medicine
(1 time)
|
---
|
2014 Characterisation of the TRIUMF neutron facility using a Monte Carlo simulation code.
|
| 49 |
thousand for a clay-rich Oxisol
(1 time)
|
Environmental Health
(1 time)
|
---
|
2007 Nitrous oxide nitrification and denitrification 15N enrichment factors from Amazon forest soils.
|
| 50 |
thousand for a sandier Ultisol
(1 time)
|
Environmental Health
(1 time)
|
---
|
2007 Nitrous oxide nitrification and denitrification 15N enrichment factors from Amazon forest soils.
|
| 51 |
thrombotic risk, whereas for antitumor necrosis factor
(1 time)
|
Hematology
(1 time)
|
IBD (1 time)
|
2015 Identification of an inflammatory bowel disease patient with a deep vein thrombosis and an altered clot lysis profile.
|
| 52 |
Thus, SM B cells produced pro-inflammatory
(1 time)
|
Medicine
(1 time)
|
BCDT (1 time)
DN (1 time)
RA (1 time)
|
2015 Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.
|
| 53 |
TiN nanofiber
(1 time)
|
Nanotechnology
(1 time)
|
ADT (1 time)
NPs (1 time)
ORR (1 time)
|
2015 Highly efficient and durable TiN nanofiber electrocatalyst supports.
|
| 54 |
titanate nano-fibrous
(1 time)
|
Biology
(1 time)
|
GAC (1 time)
PPS (1 time)
|
2016 Removing heavy metals using permeable pavement system with a titanate nano-fibrous adsorbent column as a post treatment.
|
| 55 |
titanate nanofiber
(1 time)
|
Environmental Health
(1 time)
|
GO (1 time)
|
2016 Processable graphene oxide-embedded titanate nanofiber membranes with improved filtration performance.
|
| 56 |
tmTNF
(1 time)
|
Allergy and Immunology
(1 time)
|
EAE (1 time)
MS (1 time)
|
2019 Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling.
|
| 57 |
TN flours
(1 time)
|
Chemistry
(1 time)
|
OHF (1 time)
TN (1 time)
|
2018 Changes on the phytochemicals profile of instant corn flours obtained by traditional nixtamalization and ohmic heating process.
|
| 58 |
TNF gene
(1 time)
|
Dermatology
(1 time)
|
---
|
2017 Immunology and genetics of tumour necrosis factor in allergic contact dermatitis.
|
| 59 |
TNF group and BCT group
(1 time)
|
General Surgery
(1 time)
|
BCT (1 time)
RT-PCR (1 time)
TNF-alpha (1 time)
|
2005 [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
|
| 60 |
TNF Mab
(1 time)
|
Cardiology
(1 time)
|
---
|
1992 Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.
|
| 61 |
TNF ratio
(1 time)
|
Medicine
(1 time)
|
---
|
2000 Tumour necrosis factor alpha in the diagnostic assessment of pleural effusion.
|
| 62 |
TNF receptor associated proteins with novel inhibitor protein TRAIP
(1 time)
|
Biochemistry
(1 time)
|
GPIbbeta (1 time)
GPVI (1 time)
JNK (1 time)
|
2019 Recognition of TRAIP with TRAFs: Current understanding and associated diseases.
|
| 63 |
TNF-alpha and LT-alpha
(1 time)
|
Allergy and Immunology
(1 time)
|
LT (1 time)
RAG (1 time)
|
1999 Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells.
|
| 64 |
TNF-alpha inhibitors
(1 time)
|
Gastroenterology
(1 time)
|
CD (1 time)
|
2017 Re-evaluating osteoporosis and fracture risk in Crohn's disease patients in the era of TNF-alpha inhibitors.
|
| 65 |
TNF-alpha/cachectin
(1 time)
|
Allergy and Immunology
(1 time)
|
Eos (1 time)
EPO (1 time)
HUVEC (1 time)
|
1990 Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium.
|
| 66 |
TNF-inhibitor
(1 time)
|
Epidemiology
(1 time)
|
APR (1 time)
CS (1 time)
HepC (1 time)
|
2020 Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis.
|
| 67 |
TNFA and TNFB
(1 time)
|
Genetics, Medical
(1 time)
|
SNP (1 time)
|
2003 Association of tumor necrosis factor polymorphisms with asthma and serum total IgE.
|
| 68 |
TNFDeltaARE/+
(1 time)
|
Stem Cells
(1 time)
|
CD (1 time)
EnO (1 time)
ISC (1 time)
|
2020 Intestinal Stem Cell Niche Defects Result in Impaired 3D Organoid Formation in Mouse Models of Crohn's Disease-like Ileitis.
|
| 69 |
TNFgradient
(1 time)
|
Pulmonary Medicine
(1 time)
|
CPPE (1 time)
UCPPE (1 time)
|
2005 The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.
|
| 70 |
TNFpf
(1 time)
|
Pulmonary Medicine
(1 time)
|
CPPE (1 time)
UCPPE (1 time)
|
2005 The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.
|
| 71 |
TNFserum
(1 time)
|
Pulmonary Medicine
(1 time)
|
CPPE (1 time)
UCPPE (1 time)
|
2005 The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.
|
| 72 |
TNFtg mice
(1 time)
|
Neurology
(1 time)
|
DRG (1 time)
TNFR1 (1 time)
TTX-R (1 time)
|
2017 Chronic exposure to tumor necrosis factor in vivo induces hyperalgesia, upregulates sodium channel gene expression and alters the cellular electrophysiology of dorsal root ganglion neurons.
|
| 73 |
tolerate another antitumor necrosis factor
(1 time)
|
Gastroenterology
(1 time)
|
DILE (1 time)
IBD (1 time)
|
2010 Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
|
| 74 |
tolnaftate
(1 time)
|
Chemistry Techniques, Analytical
(1 time)
|
beta-CD (1 time)
SLS (1 time)
|
2008 Highly sensitive and selective spectrofluorimetric determination of tolnaftate through the formation of ternary inclusion complex of beta-naphthol/beta-cyclodextrin/anionic surfactant system.
|
| 75 |
total number of fibers
(1 time)
|
Food Technology
(1 time)
|
AQT (1 time)
CSAF (1 time)
EQT (1 time)
|
2017 Poultry Meat Quality in Relation to Muscle Growth and Muscle Fiber Characteristics.
|
| 76 |
total number of foci
(1 time)
|
Endocrine System Diseases
(1 time)
|
Mu (1 time)
PTC (1 time)
PTS (1 time)
|
2020 Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden.
|
| 77 |
total number of muscle fiber
(1 time)
|
Food Technology
(1 time)
|
CSAF (1 time)
|
2016 Effects of Morphological Characteristics of Muscle Fibers on Porcine Growth Performance and Pork Quality.
|
| 78 |
toxin-neutralizing factor
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1972 Murine typhus toxin: studies on identification of the neutralizing factor present in normal human serum.
|
| 79 |
transcription factor controlling necrosis factor
(1 time)
|
Allergy and Immunology
(1 time)
|
HNF (1 time)
LITAF (1 time)
LPS (1 time)
|
2006 Cloning and characterization of lipopolysaccharide-induced tumor necrosis factor alpha factor promoter.
|
| 80 |
transcripts involved inflammatory cytokines
(1 time)
|
Molecular Biology
(1 time)
|
PLAC8 (1 time)
|
2006 Large-scale transcriptional analysis of bovine embryo biopsies in relation to pregnancy success after transfer to recipients.
|
| 81 |
transforming necrosis factor
(1 time)
|
Gynecology
(1 time)
|
IL (1 time)
LPS (1 time)
|
2014 Differential response to lipopolysaccharide by JEG-3 and BeWo human choriocarcinoma cell lines.
|
| 82 |
transforming nuclear factor
(1 time)
|
Allergy and Immunology
(1 time)
|
ASL (1 time)
CFTR (1 time)
ENaC (1 time)
|
2013 Modulation of ENaC, CFTR, and iNOS expression in bronchial epithelial cells after stimulation with Staphylococcus epidermidis (94B080) and Staphylococcus aureus (90B083).
|
| 83 |
transitory neurological findings
(1 time)
|
Embryology
(1 time)
|
---
|
1993 Transitory neurological findings in a population of at risk infants.
|
| 84 |
translating proactive, antitumor necrosis factor
(1 time)
|
Gastroenterology
(1 time)
|
ADAs (1 time)
PGA (1 time)
QI (1 time)
|
2020 Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease.
|
| 85 |
treated with intravenous injections of infliximab, an antitumor necrosis factor
(1 time)
|
Ophthalmology
(1 time)
|
BCVA (1 time)
BRVO (1 time)
RA (1 time)
|
2010 Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-alpha therapy for rheumatoid arthritis.
|
| 86 |
treated with monoclonal antitumor necrosis factor
(1 time)
|
Rheumatology
(1 time)
|
AAL (1 time)
CRP (1 time)
RA (1 time)
|
2007 Fucosylation of serum alpha1-acid glycoprotein in rheumatoid arthritis patients treated with infliximab.
|
| 87 |
treating MFH cells with LPS
(1 time)
|
Biology
(1 time)
|
MFH (1 time)
|
1995 Tumor necrosis factor accounts for the neutrophil emigration activity released by cultured malignant fibrous histiocytoma cells.
|
| 88 |
treatment on bone metabolism in antitumour necrosis factor
(1 time)
|
Gastroenterology
(1 time)
|
IBD (1 time)
IFX (1 time)
OC (1 time)
|
2016 A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients.
|
| 89 |
treatment, following failure of antitumour necrosis factor
(1 time)
|
Medicine
(1 time)
|
ACPA (1 time)
DAS (1 time)
Ig (1 time)
|
2016 Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab.
|
| 90 |
triangular neighborhood function
(1 time)
|
Neurology
(1 time)
|
ASIC (1 time)
GNF (1 time)
SOMs (1 time)
|
2011 A programmable triangular neighborhood function for a Kohonen self-organizing map implemented on chip.
|
| 91 |
TRIUMF Neutron Facility
(1 time)
|
Biosensing Techniques
(1 time)
|
RIA (1 time)
|
2020 Atmospheric Neutron Monitoring through Optical Fiber-Based Sensing.
|
| 92 |
true negative fraction
(1 time)
|
Biomedical Engineering
(1 time)
|
CCA (1 time)
FNF (1 time)
FPF (1 time)
|
2013 Segmentation of atherosclerotic carotid plaque in ultrasound video.
|
| 93 |
tumor necrosis factor a microsatellite
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1997 Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locus.
|
| 94 |
tumor necrosis factor alpha-induced protein
(1 time)
|
Biochemistry
(1 time)
|
5' aza-C (1 time)
ALN (1 time)
Anx5 (1 time)
|
2015 Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective.
|
| 95 |
Tumor Necrosis Factor-(Formula: see text)
(1 time)
|
Medicine
(1 time)
|
TB (1 time)
|
2013 The roles of immune memory and aging in protective immunity and endogenous reactivation of tuberculosis.
|
| 96 |
tumor necrosis factor-alpha promoter
(1 time)
|
Rheumatology
(1 time)
|
ANCA (1 time)
MPA (1 time)
MPO (1 time)
|
2003 Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis.
|
| 97 |
tumor necrosis factor-encoding gene
(1 time)
|
Molecular Biology
(1 time)
|
3'-UTR (1 time)
|
1993 Polymorphism of the mouse TNF-alpha locus: sequence studies of the 3'-untranslated region and first intron.
|
| 98 |
tumor necrosis factors -alpha and beta
(1 time)
|
Gynecology
(1 time)
|
---
|
2010 [Tumor necrosis factor in uterine leiomyomas at various stages of tumor growth].
|
| 99 |
tumor, rhTNF alpha
(1 time)
|
Neoplasms
(1 time)
|
CEA (1 time)
mAb (1 time)
|
1993 Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.
|
| 100 |
understood.Tumor necrosis factor
(1 time)
|
Cell Biology
(1 time)
|
ADAM (1 time)
iRhom2 (1 time)
PAMP (1 time)
|
2021 The Threshold Effect: Lipopolysaccharide-Induced Inflammatory Responses in Primary Macrophages Are Differentially Regulated in an iRhom2-Dependent Manner.
|
A Search Service for Abbreviation / Long Form